2005•European Journal of Clinical PharmacologyRequires access

Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects

Christian Funck‐Brentano, Pierre‐Yves Boëlle, Céline Verstuyft, Célia Bornert, Laurent Becquemont, Jean‐Marie Poirier

Open publisher page 50 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 50 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Dextromethorphan, CYP2D6, Adverse effect, CYP3A4, Pharmacology, In vivo, Medicine, Internal medicine

Back to paper search Browse research topics Original source

Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects — Research Paper | ScholarLens